Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery

Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)

NCT01428544 ·Status: COMPLETED

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

NCT00443053 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication

NCT00424281 ·Status: UNKNOWN

Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients

NCT00333021 ·Status: COMPLETED ·Phase: PHASE3

Hemorrhage Risk Prescribed Arixtra

NCT01064362 ·Status: COMPLETED

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients

NCT00521885 ·Status: TERMINATED ·Phase: NA

ARIXTRA® Adherence in SVT Patients.

NCT01691495 ·Status: COMPLETED

A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

NCT00789399 ·Status: TERMINATED ·Phase: NA

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

NCT01308528 ·Status: COMPLETED ·Phase: PHASE3

Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)

NCT00320398 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

NCT00679588 ·Status: COMPLETED ·Phase: PHASE3

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

NCT02704052 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

NCT01444612 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).

NCT00038961 ·Status: COMPLETED ·Phase: PHASE3

Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

NCT00894283 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients

NCT00493896 ·Status: TERMINATED ·Phase: PHASE3

Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism

NCT00413504 ·Status: COMPLETED ·Phase: NA

Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial

NCT06523959 ·Status: RECRUITING ·Phase: PHASE4

The Perioperative Management of Anti-thrombotic Drug Registry

NCT03695159 ·Status: COMPLETED

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

NCT05735639 ·Status: RECRUITING ·Phase: PHASE4

Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty

NCT04878497 ·Status: UNKNOWN

The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients

NCT00531843 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux

NCT00378027 ·Status: WITHDRAWN

Study to Determine Effective Dosing of Fondaparinux in Obese Persons

NCT00346879 ·Status: WITHDRAWN ·Phase: PHASE1

Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism

NCT01004939 ·Status: COMPLETED